We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Notes Reports of Liver Injury for Alli, Xenical
FDA Notes Reports of Liver Injury for Alli, Xenical
August 28, 2009
The FDA is reviewing adverse event reports of serious liver damage in patients taking two weight-loss drugs — Roche’s prescription treatment Xenical and GlaxoSmithKline’s (GSK) OTC drug Alli.